GeneDx Holdings Corp. Class A Common Stock (NASDAQ: WGS) last traded at $87.07, up 5.47% on the session. The quote above updates while this page is open; the figures below are drawn from GeneDx Holdings Corp. Class A Common Stock’s own filings and are restated only when a new one is published.
GeneDx Holdings Corp. Class A Common Stock trades on NASDAQ under the ticker WGS. Its market capitalisation is $2.60 billion.
Valuation measures for GeneDx Holdings Corp. Class A Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.60B |
|---|---|
| Enterprise value | $2.77B |
| Price / sales | 5.71 |
| Price / book | 10.63 |
| Beta | 1.45 |
Trailing-twelve-month figures tagged in GeneDx Holdings Corp. Class A Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $454.43M |
|---|---|
| Net income (TTM) | -$106.36M |
| EPS (TTM) | -$3.62 |
| Gross margin | 69.37% |
| Operating margin | -20.34% |
| Return on equity | -43.55% |
| Cash | $60.32M |
Range and volume for WGS over the past 52 weeks.
| 52-week high | $170.87 |
|---|---|
| 52-week low | $32.21 |
| Volume | 555.2K |
| Average volume | 911.6K |
| Previous close | $82.55 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.